Aida Pharmaceuticals Inc

PINK:AIDA USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.96
Market Cap Rank
#51090 Global
#15801 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.13
About

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet,… Read more

Aida Pharmaceuticals Inc (AIDA) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2008: 0.124x

Based on the latest financial reports, Aida Pharmaceuticals Inc (AIDA) has a cash flow conversion efficiency ratio of 0.124x as of September 2008.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.15 Million) by net assets ($17.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aida Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2004–2007)

This chart illustrates how Aida Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Aida Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aida Pharmaceuticals Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Aida Pharmaceuticals Inc (2004–2007)

The table below shows the annual cash flow conversion efficiency of Aida Pharmaceuticals Inc from 2004 to 2007.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2007-12-31 $21.19 Million $8.39 Million 0.396x +131.19%
2006-12-31 $15.53 Million $2.66 Million 0.171x -71.20%
2005-12-31 $10.29 Million $6.12 Million 0.595x +257.36%
2004-12-31 $6.67 Million $-2.52 Million -0.378x --